Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP

Yüksel Peker, Erik Thunström, Helena Glantz, Karl Wegscheider, Christine Eulenburg

Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017
Journal Issue: December
Disease area: Sleep and breathing disorders

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yüksel Peker, Erik Thunström, Helena Glantz, Karl Wegscheider, Christine Eulenburg. Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP. Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021


Depression and response to CPAP treatment in coronary artery disease patients with sleepy vs nonsleepy obstructive slee apnoea
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018

Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018



High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008


Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort
Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Year: 2020

Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA).
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017

Influence of obstructive sleep apnea in coronary artery disease: an 8-years-follow-up
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003

Obstructive sleep apnoea and coronary artery disease
Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities
Year: 2016



Undiagnosed COPD and overlapping obstructive sleep apnoea in coronary heart disease
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017

Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011


Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Effect of positive airway pressure on diastolic function in coronary artery disease patients with non-sleepy obstructive sleep apnea
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016


Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Changes in extracranial arteries in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 69-74
Year: 2005



Late-breaking abstract: Cardiac function in a revascularized coronary artery disease cohort with obstructive sleep apnoea with and without daytime sleepiness in the RICCADSA trial
Source: Annual Congress 2011 - Obstructive sleep apnoea in children and adults
Year: 2011

CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up
Source: Eur Respir J 2006; 28: 596-602
Year: 2006